Panion & Bf Biotech Inc.
1760.TW
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.78B
Close$
Share Statistics
| Market cap | $4.78 Billion |
|---|---|
| Enterprise Value | $4.91 Billion |
| Dividend Yield | $2.00 (3.59%) |
| Earnings per Share | $2.22 |
| Beta | -0.03 |
| Outstanding Shares | 85,671,000 |
Return
| Return on Equity | 11.46% |
|---|---|
| Return on Assets | 6.67% |
| Return on Invested Capital | 15.65% |
Valuation & Multiples
| P/E Ratio | 22.19 |
|---|---|
| PEG | 757.57 |
| Price to Sales | 2.32 |
| Price to Book Ratio | 2.65 |
| Enterprise Value to Revenue | 2.33 |
| Enterprise Value to EBIT | 14.88 |
| Enterprise Value to Net Income | 22 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.32 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$0.49
Average shareholder expectationRevenue Estimate
$522.00 M
Average shareholder expectationNext Earnings Call
Expected Date
November 17, 2026
EPS Estimate
$0.44
Average shareholder expectationRevenue Estimate
$521.00 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Panion & Bf Biotech Inc.
321 employees
CEO: Tsung-Ming Chiang Panion & Bf Biotech Inc. is a biopharmaceutical firm operating in Taiwan, engaged in the production and distribution of a diverse range of pharmaceutical goods. Its offerings cater to several key therapeutic and wellness segments, includ...